Philips expands ventilator production and launches Respironics E30 device

Philips and its manufacturing partners including Flex (producer of one of Philips’ other respiratory products) and Jabil, are working to increase production of the Philips Trilogy hospital ventilator and the Philips Respironics V60 hospital ventilator, both for invasive and non-invasive ventilation, increasing total hospital ventilator output to 4,000 units per week by the third quarter of 2020.

On April 8th this year, the FDA authorised Philips’ Respironics E30 device for emergency use in the USA during the COVID-19 public health crisis, to fill the critical hospital ventilation shortage. The new ventilator is designed for large scale production and is optimized to treat patients with respiratory insufficiency and can be used for invasive and non-invasive ventilation in the treatment of patients with COVID-19. Philips aims to produce 15,000 of these ventilators per week in April, and negotiations are already underway with relevant regulatory authorities for global distribution.

CEO of Royal Philips, Frans van Houten, said: “In line with Philips’ mission, we are fully committed to helping as many healthcare providers as possible diagnose, treat and monitor the growing numbers of COVID-19 patients. We have been mobilizing as a company to do so since January. The collaboration with our trusted partners Flex and Jabil will rapidly expand our hospital ventilator production capacity and reinforce the supply chain to enable the ramp up to a production of 4,000 hospital ventilators per week by the third quarter. To complement this, our team has developed the new Philips Respironics E30 ventilator, which can be safely used when there is limited access to a fully featured critical care ventilator. The Philips Respironics E30 ventilator can deliver a range of treatment options, and we will quickly scale its production to 15,000 units per week in April. The collaboration with our trusted partners Flex and Jabil will rapidly expand our hospital ventilator production capacity and reinforce the supply chain to enable the ramp up to a production of 4,000 hospital ventilators per week by the third quarter. To complement this, our team has developed the new Philips Respironics E30 ventilator, which can be safely used when there is limited access to a fully featured critical care ventilator.”